ZYMERGEN
Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, consumer care to pharmaceuticals, and more.
ZYMERGEN
Industry:
Artificial Intelligence (AI) Big Data Bioinformatics Machine Learning Robotics
Founded:
2013-01-01
Address:
Emeryville, California, United States
Country:
United States
Website Url:
http://www.zymergen.com
Total Employee:
501+
Status:
Active
Contact:
(415) 801-8073
Email Addresses:
[email protected]
Total Funding:
974.14 M USD
Technology used in webpage:
Domain Not Resolving Cloudflare Hosting ReCAPTCHA V2
Similar Organizations
Covariant
Covariant is an AI Robotics company developing a universal AI that enables robots to see, reason, and act on the world around them.
Cubroid Inc.
Development of modular robotics system and platform based on artificial intelligence
Genuity Science
Contract genomics organization offering robust data sourcing, data analytics and insights, and next gen sequencing for drug discovery.
iRobot
iRobot is a technology company that designs and builds behavior-based AI robots.
Luxonis
Luxonis is a spatial AI and CV platform that focuses on embedded machine learning and computer vision technology.
MetaMind
Automatic image recognition powered by artificial intelligence.
Nervana
Nervana focuses on building technology to power the next generation of intelligent applications.
Petuum
Petuum, Inc. is building a platform that serves the full spectrum of Artificial Intelligence
Tampa Bay Innovation Center
Startup accelerator for seed stage, pre-revenue #B2B and #ClimateTech founders. Apply: https://bit.ly/ClimateTech24
Third Wave Automation
Third Wave Automation provides cloud robotics and machine learning technology to material handling automation.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-05-28 | Lodo Therapeutics | Lodo Therapeutics acquired by Zymergen | N/A |
| 2020-03-19 | enEvolv | enEvolv acquired by Zymergen | N/A |
| 2018-01-08 | Radiant Genomics | Radiant Genomics acquired by Zymergen | N/A |
Investors List
SoftBank Vision Fund
SoftBank Vision Fund investment in Series D - Zymergen
DCVC
DCVC investment in Series D - Zymergen
True Ventures
True Ventures investment in Series D - Zymergen
Baron Capital
Baron Capital investment in Series D - Zymergen
Perceptive Advisors
Perceptive Advisors investment in Series D - Zymergen
Baillie Gifford
Baillie Gifford investment in Series D - Zymergen
Employee Stock Option Fund
Employee Stock Option Fund investment in Series D - Zymergen
Armentum Partners
Armentum Partners investment in Debt Financing - Zymergen
Mission BioCapital
Mission BioCapital investment in Series C - Zymergen
Hanwha Asset Management
Hanwha Asset Management investment in Series C - Zymergen
Newest Events participated
Participated in Lesbians Who Tech London Summit 2017
on 2017-11-10 as sponsor
Key Employee Changes
| Date | New article |
|---|---|
| 2021-02-24 | Zymergen Appoints Global Finance Expert Enakshi Singh as Chief Financial Officer |
Official Site Inspections
http://www.zymergen.com
- Host name: 172.67.211.46
- IP address: 172.67.211.46
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Zymergen"
Zymergen - Crunchbase Company Profile & Funding
Zymergen is a biotechnology company that specializes in the fields of machine learning, big data, and artificial intelligence. The company partner with nature to create materials and products across industries from agriculture to electronics, …See details»
Zymergen | World Economic Forum
Jan 11, 2024 Zymergen is the world’s first molecular manufacturing technology company, ushering in a new age of manufacturing and industrial innovation. A World Economic Forum …See details»
Zymergen Company Profile 2024: Valuation, Funding & Investors
Zymergen General Information Description. Developer of microbe-based diversified inputs and technology intended for agricultural and industrial applications. The company specializes in …See details»
Zymergen - Contacts, Employees, Board Members, Advisors
Organization. Zymergen . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 15. ... Zymergen has 6 …See details»
Working At Zymergen: Company Overview and Culture - Zippia
Mar 14, 2024 Zymergen researches, develops, and manufactures microbes for Fortune 500 companies. It develops molecules for agriculture, chemicals, materials, pharmaceuticals, …See details»
Zymergen - Funding, Financials, Valuation & Investors - Crunchbase
Zymergen is registered under the ticker NASDAQ:ZY . Their stock opened with $31.00 in its Apr 22, 2021 IPO. Zymergen is funded by 30 investors. SoftBank Vision Fund and DCVC are the …See details»
Zymergen Company Profile - Office Locations, Competitors ... - Craft
Zymergen is a company that researches, develops, and manufactures microbes for industrial applications. It develops molecules for biomedical coatings and adhesives that can be used as …See details»
As Biology Manufacturing Company Zymergen Implodes ... - Forbes
Aug 4, 2021 Zymergen’s stock dropped 69% in after-hours trading, shaving nearly $2.5 billion from its market value. ... and I am proud of the work our teams are doing across the …See details»
Zymergen - LinkedIn
Zymergen | 31,957 followers on LinkedIn. Zymergen is now a part of Ginkgo Bioworks!See details»
Ginkgo Bioworks Completes Acquisition of Zymergen
Oct 19, 2022 Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo …See details»
7 months after biotech pivot, Zymergen is acquired by Ginkgo
Jul 25, 2022 The terms of the deal have already been agreed upon by the boards of both companies, with Zymergen stockholders receiving 0.9179 of a Ginkgo share for each …See details»
Ginkgo Bioworks Completes Acquisition of Zymergen
Oct 19, 2022 Under the terms of the merger agreement entered into on July 24, 2022, Zymergen stockholders received, for each share of Zymergen common stock, 0.9179 shares of Ginkgo …See details»
With $300 Million In New Funding, Zymergen Aims To Sustainably …
Oct 10, 2020 In September, Zymergen announced one of the largest deep tech investments of 2020 — $300 million — to accelerate its pipeline of high-performance chemicals and materials.See details»
This Is Why Zymergen's IPO Was a Huge Success | The Motley Fool
Apr 27, 2021 A capital magnet Between December 2018 and its IPO, Zymergen raised $700 million from investors as a private company. On April 21, the company took in another $500 …See details»
What is Zymergen's business model? - Vizologi
Zymergen operating within the biotechnology industry is at the forefront of integrating advanced automation machine learning and genomics to dramatically expedite scientific advancements …See details»
The Inside Story Of How SoftBank-Backed Zymergen Imploded …
Oct 13, 2021 Zymergen’s new management has said that it will need to cut expenses, and industry observers expect massive staff cuts, perhaps 50% or more. In September, Zymergen …See details»
Ginkgo to acquire Zymergen for $300m - Pharmaceutical …
Jul 26, 2022 In addition, Zymergen will progress its cost restructuring measures, including headcount reductions and programme optimisation. The transaction received unanimous …See details»
Zymergen Announces Emerging Drug Discovery Business Enabled …
Jan 10, 2022 Exploring natural products for innovative therapeuticsSAN FRANCISCO, Jan. 09, 2022 (GLOBE NEWSWIRE) -- Biotechnology company Zymergen (ZY) announced a new drug …See details»
Zymergen - YouTube
We are a science and material innovation company rethinking biology and reimagining the world. A World Economic Forum Tech Pioneer, we partner with nature to create never-before …See details»
DCVC Denied Final Judgments in Zymergen Securities Fraud Case
1 day ago DCVC Management Co.'s motion for a partial final judgment in a securities fraud case against it was dismissed by a federal court. Investors alleged that DCVC and two other …See details»